Considerations for diabetes translational research in real-world settings.

  title={Considerations for diabetes translational research in real-world settings.},
  author={Sanford A. Garfield and Saul N. Malozowski and Marshall H. Chin and K. M. Venkat Narayan and Russell E. Glasgow and L. W. Green and Roland G. Hiss and Harlan M. Krumholz},
  journal={Diabetes care},
  volume={26 9},
“IDDK’s mission is to conduct and support research on diseases such as diabetes in order to increase knowledge to improve the public’s health. NIDDK’s goals will not be completely achieved until the knowledge gained from the research it supports is translated and fully applied.”—Allen Spiegel, MD, Director, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 27 September 2002 (1). Tremendous advances have occurred in diabetes research over the past decade. Landmark… 

Tables from this paper

Quality improvement in diabetes—successful in achieving better care with hopes for prevention
The effectiveness and cost‐effectiveness data regarding QI strategies in diabetes care are summarized and the potential role of quality monitoring and QI in trying to implement primary prevention of diabetes more widely and effectively is discussed.
Analysis of the REMEDIES 4D clinical trial: a redesign of primary care to overcome clinical inertia and improve outcomes
This dissertation provided supporting evidence that CDEs in the primary care practice can improve patient’s outcomes and since CDEs focus on clinical and behavioral factors, they can better support patients’ behavioral and clinical goals.
Integrating the prevention and management of type 2 diabetes in real world settings
The thesis discusses how disparities between idealism and the ‘life world’ of patients might be addressed, adding to current debates about shared understanding and the importance of taking into account behavioural influences that might undermine or enhance the achievement of shared goals.
Solution-based science to prevent and control diabetes in underserved communities around the world (commentary, for Diabetes special section).
  • A. King
  • Medicine
    Translational behavioral medicine
  • 2020
The articles contained in the Diabetes special section were reviewed, with a focus on the advances made with this type of research and the challenges that came to light and numerous strengths of the large-scale translational studies were identified.
[Translational research in gestational diabetes mellitus and mild gestational hyperglycemia: current knowledge and our experience].
It is expected that translational research in the binomial diabetes and pregnancy are implemented in centers of excellence, in both basic and applied research, and complemented by multicenter clinical studies, conducted in a pragmatic way to increase the level of scientific evidence with more reliable diagnostic and propaedeutic resources.
Preventing diabetes in the clinical setting
Strong evidence exists for the prevention or delay of type 2 diabetes through lifestyle changes throughifestyle changes and components of these programs may be adaptable for use in clinical settings.
Special Feature Type 2 Translational Research for CKD
The need for type 2 translational research in CKD is urgent because of preventable human suffering and unsustainable costs of providing care, and theory, framework, and approaches suggested may help meet that challenge.
Translation Research in Diabetes
The burden of diabetes is well documented, and the disease is disproportionately high among youth with minority ethnic and racial backgrounds and the annual direct and indirect economic costs of diabetes in the Unites States are approx $132 billion.
Type 2 translational research for CKD.
Strategies to effectively treat people with CKD have been identified by conventional clinical research. Despite this evidence, awareness, screening, detection, diagnosis, risk factor control,
Type 2 diabetes prevention from research to practice : the SLIMMER lifestyle intervention
This study showed that a thorough preparation of translation and implementation has led to a cost-effective intervention to prevent type 2 diabetes which is feasible to implement in Dutch primary health care.


The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic.
The Diabetes Quality Improvement Project (DQIP) is described, which has developed and implemented a comprehensive set of national measures for evaluation for diabetes care, which will enhance uptake of research into practice and may ultimately improve diabetes care and clinical outcomes.
Translation research for chronic disease: the case of diabetes.
It is argued that efficacy or mechanism research, which is aimed at understanding the causes of disease and the efficacy of treatments, cannot ameliorate the burden of chronic disease without more concomitant translation research to change and improve clinical practice at the population level.
The concept of diabetes translation: addressing barriers to widespread adoption of new science into clinical care.
This commentary addresses the approach that the Michigan Diabetes Research and Training Center (MDRTC) has used to fulfill the responsibility of conducting translation, and describes the efforts to address barriers between current scientific advances in the understanding of diabetes and what is routinely practiced.
Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research.
Progress in translation research and successes in translating the subsequent landmark clinical trials into practice are and will continue to be a result of the research conducted by the DRTCs.
Nurse Case Management To Improve Glycemic Control in Diabetic Patients in a Health Maintenance Organization
A 12-month randomized, controlled trial compared a nurse case management model of diabetes care with usual diabetes management in a primary care setting and showed a strong association between algorithm-directed nurse interventions and improved glycemic control.
Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
Intensive glycemic control and reduction in serum cholesterol level increase costs and improve health outcomes and the cost-effectiveness ratios for these 2 interventions are comparable with several other frequently adopted health care interventions.
Central challenges facing the national clinical research enterprise.
The goal of this article is to articulate the 4 central challenges facing clinical research at present--public participation, information systems, workforce training, and funding; to make recommendations about how they might be addressed by particular stakeholders; and to invite a broader, participatory dialogue with a view to improving the overall performance of the US clinical research enterprise.
A Diabetes Report Card for the United States: Quality of Care in the 1990s
There is a substantial gap between the recommended and actual care of diabetes in the United States between 1988 and 1995, and U.S. national data is used to provide a reference and benchmark of the quality of diabetes care as measured by the DQIP indicators.
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus
Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.